# Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma

> **NCT00813150** · PHASE3 · COMPLETED · sponsor: **Janssen-Cilag G.m.b.H** · enrollment: 96 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Bortezomib
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00813150
- **Lead sponsor:** Janssen-Cilag G.m.b.H
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2014-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813150, "Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00813150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*